Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Merck
Harvard Business School
US Army
Julphar
Cipla
Covington
Johnson and Johnson
Medtronic

Generated: December 10, 2017

DrugPatentWatch Database Preview

NIACIN Drug Profile

« Back to Dashboard

Which patents cover Niacin, and when can generic versions of Niacin launch?

Niacin is a drug marketed by Amneal Pharms, Barr, Lannett, Lupin Ltd, Sun Pharma Global, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Mk Labs, Purepac Pharm, Sandoz, Tablicaps, Watson Labs, and Wockhardt. and is included in twenty-three NDAs.

The generic ingredient in NIACIN is niacin. There are fourteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the niacin profile page.
Drug patent expirations by year for NIACIN

Pharmacology for NIACIN

Ingredient-typeNicotinic Acids
Drug ClassNicotinic Acid

Medical Subject Heading (MeSH) Categories for NIACIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Amneal PharmsNIACINniacinTABLET, EXTENDED RELEASE;ORAL203578-002Jul 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsNIACINniacinTABLET;ORAL083115-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsNIACINniacinTABLET;ORAL083136-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettNIACINniacinTABLET, EXTENDED RELEASE;ORAL203899-002Jun 16, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrNIACINniacinTABLET, EXTENDED RELEASE;ORAL076250-001Apr 14, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalNIACINniacinTABLET, EXTENDED RELEASE;ORAL200484-002Apr 23, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mk LabsNIACINniacinTABLET;ORAL083525-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettNIACINniacinTABLET, EXTENDED RELEASE;ORAL203899-001Jun 16, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsNIACINniacinTABLET;ORAL083180-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtNIACINniacinTABLET;ORAL081134-001Apr 28, 1992AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
Colorcon
Cerilliant
Novartis
Farmers Insurance
Baxter
Daiichi Sankyo
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot